Neogen Corporation (NG2)
XDUS
Real-time Data
06:00 AM
Day's Range
9.8152 wk Range
4.36Overview - NG2 - Neogen Corporation
Key Statistics
Valuation
P/E (Trailing)
‪-245.60‬
PEG Ratio
‪2.50‬
Price / Book
‪1.02‬
Profitability
Gross Margin
‪47.84%‬
Profit Margin
‪46.93%‬
Operating Margin
‪5.58%‬
Return on Assets
‪-0.23%‬
Return on Equity
‪-0.37%‬
Ownership
Shares Outstanding
217.70M
Price stats
50-Day Avg
‪8.80‬
200-Day Avg
‪7.79‬
Peers - NG2 - Neogen Corporation
Peer Comparison
Compared with companies in Diagnostics & Research listed on XDUS.
- NG2XDUSNeogen Corporation+51.76%52-week change-245.65P/E (Trailing)‪46.93%‬Profit Margin
- NL0XDUSGrail, Inc.+58.61%52-week change-6.28P/E (Trailing)‪-236.94%‬Profit Margin
- 0MEXDUSTwist Bioscience Corporation+82.13%52-week change-101.08P/E (Trailing)‪50.72%‬Profit Margin
- 1K9XDUSCareDx Inc.+74.13%52-week change-109.00P/E (Trailing)‪67.55%‬Profit Margin
- 04XXDUSPersonalis Inc.+71.88%52-week change-15.98P/E (Trailing)‪22.65%‬Profit Margin
- 5GHXDUSGuardant Health Inc.+61.09%52-week change-42.33P/E (Trailing)‪64.46%‬Profit Margin
- NG9XDUSNeoGenomics Inc.+60.23%52-week change-16.91P/E (Trailing)‪43.21%‬Profit Margin
Profile Summary - NG2 - Neogen Corporation
About
Neogen Corporation develops, manufactures, and markets products and services dedicated to food and animal safety worldwide. Operating through two primary segments, Food Safety and Animal Safety, the company provides diagnostic test kits, dehydrated culture media, and complementary solutions to detect foodborne…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
